Mark R Barakat - Retinal Consultants of Arizona

基本信息

浏览量：8

职业迁徙

个人简介

暂无内容

研究兴趣

论文共 48 篇作者统计合作学者相似作者

按年份排序按引用量排序主题筛选期刊级别筛选合作者筛选合作机构筛选

Safety and Tolerability of Suprachoroidal Axitinib Injectable Suspension, for Neovascular Age-related Macular Degeneration; Phase I/IIa Open-Label, Dose-Escalation Trial

Mark R. Barakat,David Brown,Allen Hu,Rahul N. Khurana,Dennis Marcus,Joel Pearlman,Charles C. Wykoff,Barry Kapik,Thomas Ciulla

OPHTHALMOLOGY SCIENCEno. 1 (2025)

引用0浏览0WOS引用

Human Factors Studies to Assess the Usability of the Faricimab Prefilled Syringe

Mark R Barakat, Henry M Kwong, Gelson Marcon, Olivia E O'Leary,Liliana P Paris, Petrick Schneider,Yannan Tang,Jordan M Graff

Clinical ophthalmology (Auckland, NZ) (2025): 395-406

引用0浏览0WOS引用

Transforming Retinal Disease Management Through Diabetes Care

Catherine M Lockhart,Mark R Barakat, Jeffrey D Dunn, Terry Richardson, Tori Bratcher, Estay Greene, Michael Kobernick,Doron Schneider, Jeremy Wigginton

Journal of managed care & specialty pharmacyno. 4-a Suppl (2025): S1-S11

引用0浏览0WOS引用

Impact of Baseline Vision on Outcomes in Diabetic Macular Edema in VISTA/VIVID

Michael A. Singer,Dilraj S. Grewal, Preston O’Brien,Fabiana Silva,Weiming Du, Guruprasad B,Hadi Moini,Mark R. Barakat

Ophthalmology Retina（2025）

引用0浏览0WOS引用

Phase 1 DAVIO Trial: EYP-1901 Bioerodible, Sustained-Delivery Vorolanib Insert in Patients with Wet Age-related Macular Degeneration

Sunil Patel,Philip P. Storey,Mark R. Barakat,Vrinda Hershberger,William Z. Bridges,David A. Eichenbaum,David R. Lally,David S. Boyer, Sophie J. Bakri,Monica Roy,Dario A. Paggiarino

Ophthalmology Sciencepp.100527, (2024)

引用0浏览0引用

Retinal Fluid Quantification Using a Novel Deep Learning Algorithm in Patients Treated with Faricimab in the TRUCKEE Study

Aamir A. Aziz,Arshad M. Khanani,Hannah Khan, Eileen Lauer,Ibrahim Khanani,Ohidul Mojumder, Zoha A. Khanani,Huma Khan,Greggory M. Gahn, J. Taylor Graff,Ashkan M. Abbey,David R. P. Almeida,Mark R. Barakat,Giulia Corradetti,Jordan M. Graff,Sara J. Haug,Jared S. Nielsen,Veeral S. Sheth,SriniVas R. Sadda, Ilan Hadas,Gidi Benyamini, Kester Nahen, Nishant Mohan

EYE (2024)

引用0浏览0WOSNATURE引用

Design and Rationale of a Randomized Trial of COBRA PzF Stenting to REDUCE Duration of Triple Therapy (COBRA-REDUCE)

Robert A. Byrne,Roisin Colleran,J. J. Coughlan,Rajiv Jauhar,Luc Maillard,Axel De Labriolle,Michael Maeng, Charles Croft, Michael Brunner, David Leistner,Bernhard Zrenner, Marc Kollum,Karl-Ludwig Laugwitz,Erion Xhepa,Katharina Mayer,Shqipdona Lahu,Michael Joner,Ajay Kirtane,Roxana Mehran,Mark Barakat,Philip Urban,Donald E. Cutlip,Adnan Kastrati

CIRCULATION-CARDIOVASCULAR INTERVENTIONS（2024）

引用9浏览0WOS引用

Suprachoroidal Space Injection Technique: Expert Panel Guidance

Charles C Wykoff,Robert L Avery,Mark R Barakat,David S Boyer,David M Brown,Alexander J Brucker,Emmett T Cunningham,Jeffrey S Heier,Nancy M Holekamp,Peter K Kaiser,Arshad M Khanani,Judy E Kim,Hakan Demirci,Carl D Regillo,Glenn C Yiu,Thomas A Ciulla

Retinano. 6 (2024): 939-949

引用0浏览0WOS引用

Phase I DAVIO Trial: EYP-1901 Bioerodible, Sustained-Delivery Vorolanib Insert in Patients with Wet Age-Related Macular Degeneration

Sunil Patel,Philip P. Storey,Mark R. Barakat,Vrinda Hershberger,William Z. Bridges,David A. Eichenbaum,David R. Lally,David S. Boyer,Sophie J. Bakri,Monica Roy,Dario A. Paggiarino

OPHTHALMOLOGY SCIENCEno. 5 (2024)

引用0浏览0WOS引用

Safety and Tolerability of Suprachoroidal Axitinib, CLS-AX, for Neovascular AMD; Phase 1/2a Open-Label, Dose-Escalation Trial

Mark R. Barakat,David Brown,Allen Hu,Rahul N. Khurana,Dennis Marcus,Joel Pearlman,Charles Wykoff,Barry Kapik,Thomas Ciulla

Ophthalmology Sciencepp.100586-100586, (2024)

引用0浏览0引用

加载更多

作者统计

合作学者

合作机构

D-Core

合作者
学生
导师

暂无相似学者，你可以通过学者研究领域进行搜索筛选

数据免责声明

页面数据均来自互联网公开来源、合作出版商和通过AI技术自动分析结果，我们不对页面数据的有效性、准确性、正确性、可靠性、完整性和及时性做出任何承诺和保证。若有疑问，可以通过电子邮件方式联系我们：report@aminer.cn